Other pulm dx Flashcards
objectives
Pulmonary embolism
- Pulmonary Thromboembolism: passage of a clot from the venous system that lodges in a pulmonary artery
- Venous thromboembolism (VTE) is the third MC CV illness
- Symptoms: variable
- MC dyspnea followed by pleuritic CP, symptoms of DVT and cough
- Sudden death can occur
- PE: tachypnea and tachycardia
PE gold standard Dx
- Gold standard: catheter-based pulmonary angiography but this is RARELY used
- For pts where interventional therapy is indicated bc it can combine interventions for clot lysis and diagnosis in one scan
- This will tell you yes or no regardless of how costly/invasive. Not first line a lot!
PE dx
- Combo of pretest probability, D-dimer, definitive diagnostic imaging, spiral CT pulm angiography (CTPA) and less commonly ventilation perfusion scanning
PE pre-test, wells score
-
To determine pretest: Wells Score
- 0-2 pts- low risk
- 3-6 pts – moderate risk
- over 6 pts- high risk of PE
- Criteria: suspected dvt 3, alternate dx 3, tachycardia1.5 , post-surgery/disabled in last 4 wks 1.5, previous dvt/pe 1.5, hemoptysis 1 , malignancy past 6 months 1 (causes hypercoag state)
-
For modified wells score: what is used now!
- Over 4, PE is likely
- Under 4, PE is unlikely
PE d-dimer
- D-Dimer testing: to r/u PE w/unlikely PE pts……………… (TO EXCLUDE PE)
- You will order this first if PE is unlikely
- D-dimers are degradation products of crosslinked fibrin that reflects ongoing activation of hemostatic and thrombolytic system.
- Elevated D-dimer should prompt further testing with diagnostic imaging > 500
- Healthy individuals have a minimal d-dimer
- You CANNOT make a dx of a PE using only d-dimer because you can get false positives (higher w/pregnancy/trauma/surgery/over 50)
PE CTPA
-
CTPA: First choice diagnostic imaging modality; if PE is likely, get a CTPA- also called CT w/PE protocol
- What is the process? 90% sensitive test
- Images acquired when pt is holding their breath during pulmonary arterial enhancement phase after IV contrast injection.
- The PE will appear as a filling defect in the opacificed pulmonary artery
- You can also use this to disclose causes of hypoxemia
- Use on pts with moderate to high risk of PE! Not for low risk pts
- What is the process? 90% sensitive test
- If the CTPA is inconclusive and cannot confirm or deny PE, then you need more testing.
- V/Q scan, contrast pulmonary angiography, US, MRI pulmonary angiography
When to consider using Lung V/Q scan: gamma camera (doesn’t use iodine contrast) for PE
- Nuclear Medicine scan with radiopharm (IV and inhalation) that creates an image of air and blood flow patterns in lungs
- Use when CTPA is contraindicated such as with renal insufficiency and hx of severe contrast allergy or if CTPA is inconclusive
- You compare ventilation to perfusion and look for mismatches to indicate PE.
CXR for PE
- nonspecific as well
- When ordering CXR, you are looking for alternative causes to the pts symptoms.
- Nonspecific abnormalities are common on CXR for PE but many have normal CXR
- Possible signs: not common though
- Hampton’s Hump: shallow, hump-shaped opacity in the periphery of the lung, with its base against the pleural surface and hump towards the hilum
- Pulmonary infarction
- Hampton’s Hump: shallow, hump-shaped opacity in the periphery of the lung, with its base against the pleural surface and hump towards the hilum
- Westermark’s sign: demonstration of a sharp cut-off of pulmonary vessels with distal hypoperfusion in a segmental distribution within the lung
- “less whiteness” aka less vasculature
EKG for PE
- EKG for PE: nonspecific as well
- Sometimes: S1Q3 pattern
USPSTF recommendations regarding screening for lung cancer
- Lung cancer is MCC of cancer death in both genders
- 90% due to smoking
- Symptoms:
- Dyspnea, non-productive cough, hemoptysis, pleuritic CP, hoarseness (if presses on laryngeal nerve), pleural effusion, wt loss ~~> advanced disease
- Screening:
- Do not use CXR for SCREENING. They do not reduce mortality.
-
CT screening offered to:
-
Smoker and former smokers 55-74 yo with more than 30 pack-years
- Annual low dose CT scanning
-
Smoker and former smokers 55-74 yo with more than 30 pack-years
- NOT for pts:
- Less than 30 pack-years, outside ages, w/severe comorbidities that could dec ability to cure it or limit life
techniques utilized to diagnose and stage lung cancer to include CT scanning, PET scanning, bronchoscopy with endobronchial ultrasound (EBUS)-directed biopsy, and transthoracic needle biopsy.
- To diagnosis:
Imaging: use imaging to optimize selection of biopsy site and preferred modality to get sample.
- CXR (PA and lat) is first line imaging choice
- Eventually, every pt should get a CT of chest and upper abdomen to evaluate extent of
Primary tumor and potential spread to liver and adrenal glands
- Pet scan can be used sometimes to evaluate mediastinal LN involvement if sx is option
Tissue biopsy: the cancer diagnosis is based on pathologic evaluation of cytologic of histopathologic specimens
- Cytology: get from thoracentesis or sputum cytology
- More protein and more LDH will be present
- Malignancy will most likely be unilateral
- Bronchoscopy w/biopsy: if malignancy is more centrally located
- Bronchoscopy w/EBUS-directed biopsy is common due to high diagnostic accuracy for getting central primary tumor and most mediastinal LN
- EBUS: used to dx lung cancer, lung infections, enlarged LN/masses in chest
- Uses US with scope to visualize airway wall and structures that guides transbronchial needle aspiration samples (termed TBNA)
- Helpful for biopsy; localizes what’s just outside of bronchi
- Minimally invasive
- For squamous cell carcinomas- you can see this a lot since they lie in the bronchi
- Uses US with scope to visualize airway wall and structures that guides transbronchial needle aspiration samples (termed TBNA)
- EBUS: used to dx lung cancer, lung infections, enlarged LN/masses in chest
- Bronchoscopy w/EBUS-directed biopsy is common due to high diagnostic accuracy for getting central primary tumor and most mediastinal LN
- Transthoracic needle biopsy (TTNB) : peripheral
- Can obtain tissue for accurate diagnosis of peripheral lung nodules/masses
- May use CT and US to guide
- CT is MC
- Complications: pneumothorax is MC and hemoptysis
- May use CT and US to guide
- Can obtain tissue for accurate diagnosis of peripheral lung nodules/masses
Two major tests for latent TB
-
TST and IGRA
- Evaluates cell- mediated Immunity
Latent: LTBI- no symptoms
- Clinical diagnosis established by demonstrating prior TB infection and excluding active TB disease
- Latent symptoms: positive TST and positive IGRA, negative sputum smear, stable calcified granulomas
Active TB: latent can become active especially when become immunocompromised
- Five classic symptoms: cough of 3 weeks, hemoptysis, wt loss, fever, night sweats
- Infectious, positive TST, positive IGRA, abnormal findings
- Culturing sputum for growth of m. tb + staining acid-fast
PPD testing: also known as TST
- Once you place it, make sure you see a Intradermal bleb.
- Measure longest horizontal diameter in mm of raised/induration reaction 48-72 hours
- Not erythema/redness
- Only record in mm. do not record as positive or negative
- Positive: measurement + pt’s pretest probability
- <5 HIV w/close contact to active contagious case
- >5 immunocompromised, + CXR
- Healthcare workers: > 10 mm
- Health ppl > 15 mm